These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pressure-volume relationship during dobutamine stress echocardiography predicts exercise tolerance in patients with congestive heart failure.
    Author: Ciampi Q, Pratali L, Bombardini T, Della Porta M, Petruzziello B, Villari B, Picano E, Sicari R.
    Journal: J Am Soc Echocardiogr; 2010 Jan; 23(1):71-8. PubMed ID: 19962273.
    Abstract:
    BACKGROUND: The pressure-volume relationship (PVR) is a useful method for evaluating left ventricular (LV) myocardial contractility during dobutamine stress echocardiography (DSE). The investigators assessed PVRs, systolic and diastolic function, B-type natriuretic peptide (BNP) levels, and aerobic exercise capacity in patients with congestive heart failure (CHF). METHODS: A total of 84 patients with CHF (mean age, 68 +/- 9 years) underwent high-dose DSE. PVR was defined as the systolic cuff pressure/end-systolic volume index difference between rest and peak DSE. Of these, 67 patients also underwent cardiopulmonary exercise testing. The patients were divided into 3 equal groups on the basis of PVR: lower, intermediate, and higher. RESULTS: PVRs were significantly lower in more symptomatic patients (New York Heart Association class II vs III) (2.17 +/- 1.99 vs 0.91 +/- 0.72 mm Hg/mL/m(2), P < .001). Patients with elevated LV filling pressures (E/Ea >or= 14) showed significantly lower PVRs compared with patients with normal or slightly abnormal LV filling pressures (1.1 +/- 1.1 vs 2.96 +/- 3.11 mm Hg/mL/m(2), P = .006). Patients with higher PVRs showed lower logarithmically transformed BNP levels (2.0 +/- 0.5, 2.5 +/- 0.3, and 2.6 +/- 0.5 pg/mL; P < .001), higher peak oxygen consumption (17 +/- 4, 13 +/- 3, and 12 +/- 3 mL/kg/min; P < .001), and higher rest-stress percentage changes in ejection fraction (80 +/- 50%, 56 +/- 29%, and 22 +/- 32%; P < .001) compared with patients with intermediate and lower PVRs, respectively. The parameters predictive of exercise tolerance were PVR (odds ratio [OR]; 1.582, 95% confidence interval [CI], 1.136-2.204; P = .007), ejection fraction (OR, 1.172; 95% CI, 1.070-1.283; P = .001), log BNP (OR, 0.080; 95% CI, 0.020-0.325; P < .001), and E/Ea (OR, 0.836; 95% CI, 0.733-0.953; P = .007). CONCLUSIONS: In patients with CHF, impaired noninvasively assessed myocardial contractility is related to impaired systolic and diastolic function, higher BNP levels, and poorer exercise tolerance.
    [Abstract] [Full Text] [Related] [New Search]